Dogwood Therapeutics
DWTX
21 hedge funds and large institutions have $331K invested in Dogwood Therapeutics in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 20 → 21 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.88% less ownership
Funds ownership: 4.47% → 3.58% (-0.88%)
33% less capital invested
Capital invested by funds: $493K → $331K (-$163K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.5K |
| 2 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$8.56K |
| 3 |
Jane Street
New York
|
+$7.63K |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$5.43K |
| 5 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$2.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$119K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$13.1K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$9K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$2.64K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.5K |
DWTX Hedge Fund Activity: Q1 2024 in Review
21 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2024, worth a combined $331K — down 33% from $493K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new DWTX positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $10.5K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $119K sold.
- 21 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2024, up from 20 in Q4 2023.
- Funds reported $331K of Dogwood Therapeutics stock for Q1 2024, down 33% quarter-over-quarter.
- 5 funds opened new Dogwood Therapeutics positions in Q1 2024 and 4 closed out, a net change of +1 holder.
- The largest Dogwood Therapeutics buyer in Q1 2024 was Susquehanna International Group, an estimated $10.5K added.
- The largest Dogwood Therapeutics seller in Q1 2024 was Renaissance Technologies, an estimated $119K sold.
Based on aggregated 13F filings for Q1 2024.